HBCM
ETON icon

Heron Bay Capital Management’s Eton Pharmaceutcials ETON Stock Holding History

Heron Bay Capital Management’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-11,515
Closed -$50.4K – 109
2023
Q4 		$50.4K Buy
11,515
+485
+4% +$1.94K 0.01% 92
2023
Q3 		$46K Buy
+11,030
New +$42.6K 0.01% 93

Other funds holding ETON

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AI
Acuitas Investments Seattle, Washington $1.43M AUM 17.52% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $9.38B AUM 33.37% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Heron Bay Capital Management's ETON Position: Q1 2024 in Review

Heron Bay Capital Management sold out of Eton Pharmaceutcials (ETON) in Q1 2024, closing a stake of 11,515 shares — an estimated $50.4K sold.

Heron Bay Capital Management first reported a position in ETON in Q3 2023 and held it in 2 quarters. The position peaked at $50.4K in Q4 2023. 44 funds tracked by Wall St. Rank hold ETON as of Q1 2024.

  • Heron Bay Capital Management reported no remaining Eton Pharmaceutcials position as of Q1 2024 after selling out during the quarter.
  • Heron Bay Capital Management sold 11,515 Eton Pharmaceutcials shares in Q1 2024, an estimated $50.4K.
  • Heron Bay Capital Management first reported a position in Eton Pharmaceutcials in Q3 2023 and held it in 2 quarters.
  • Heron Bay Capital Management's Eton Pharmaceutcials position peaked at $50.4K in Q4 2023.
  • 44 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q1 2024.

Based on Heron Bay Capital Management's 13F filing for Q1 2024, filed 14 May 2024.